600+ sources. One page. See who else covered it.
When he first pitched investors on his startup in the fall of 2024, Dave Johnson felt like he was selling an unpopular idea. The typical VC response to his proposed pharma lab services company was: ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.
Anthony Fauci's recent appearance before Congress is a good reminder that his reign of error during COVID would not have been possible without a deeply partisan and starstruck press.
At least 844 children have died and more than 112,000 people have sought hospital treatment for the preventable disease since March 15.
People with hidden antagonistic traits may struggle to forgive others on a deeply automatic level. New research indicates that unconscious narcissism is linked to interpersonal avoidance and reduced…
BioNTech has tapped Sobi’s Guido Oelkers as its new CEO, who will start Feb. 1, 2027, at the latest. Sobi also said Monday it is on the lookout for his replacement. ...